IMMUNOMODULATORY ACTIVITY OF NIVOLUMAB IN METASTATIC RENAL CELL CARCINOMA (MRCC): ASSOCIATION OF BIOMARKERS WITH CLINICAL OUTCOMES

被引:0
作者
Choueri, Toni K. [1 ]
Fishman, Mayer N. [2 ]
Escudier, Bernard [3 ]
McDermott, David F. [4 ]
Kluger, Harriet [5 ]
Stadler, Walter M. [6 ]
Perez-Gracia, Jose L. [7 ]
McNeel, Douglas [8 ]
Curti, Brendan [9 ]
Harrison, Michael R. [10 ]
Plimack, Elizabeth R. [11 ]
Appleman, Leonard [12 ]
Fong, Lawrence [13 ]
Drake, Charles G. [14 ]
Young, Tina C. [15 ]
Chasalow, Scott D. [15 ]
Ross-Macdonald, Petra [15 ]
Simon, Jason S. [15 ]
Walker, Dana [15 ]
Sznol, Mario [5 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[3] Inst Gustave Roussy, Villejuif, France
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Univ Chicago, Med, Chicago, IL 60637 USA
[7] Univ Navarra Clin, Pamplona, Spain
[8] Univ Wisconsin, Dept Med, Madison, WI USA
[9] Providence Portland Med Ctr, Providence Canc Ctr, Portland, OR USA
[10] Duke Univ, Med Ctr, Durham, NC USA
[11] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[12] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[13] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[14] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[15] Bristol Myers Squibb Co, Princeton, NJ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
189
引用
收藏
页码:119 / 119
页数:1
相关论文
empty
未找到相关数据